"Ligands act like keys binding selectively to locks in the body, effectively targeting cancer cells to deliver therapeutic agents like Lutetium-177 with precision."
"PSMA is the lock found on prostate cells, with cancerous cells expressing it at much higher levels, making PSMA-617 therapy highly selective for aggressive tumors."
"The number of PSMA molecules in cancer cells directly correlates with the effectiveness of Lutetium PSMA therapy, especially in higher-grade tumors that are more metastatic."
Collection
[
|
...
]